Form 4 for ABT Abbott Laboratories
Accepted 2021-12-21 00:00:00 ET · period of report 2021-12-17 · accession 0001415889-21-006162 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-21 | 2021-12-17 | ABT | Morrone Louis H. | SVP | S - Sale+OE | $137.54 | -9,988 | 38.2K | -21% | -$1.37M |
| D | 2021-12-21 | 2021-12-17 | ABT | Morrone Louis H. | SVP | M - OptEx | $48.34 | +9,988 | 48.2K | +26% | +$482.8K |
| D | 2021-12-21 | 2021-12-17 | ABT | Morrone Louis H. | SVP | M - OptEx | $0.00 | -9,988 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2021-12-17 | S | D | 9,988 | $137.54 | 38,229 | D | — | — | |
| 2 | Common | Common shares without par value | 2021-12-17 | M | A | 9,988 | $48.34 | 48,217 | D | — | — | |
| 3 | Derivative | Option (right to buy) | 2021-12-17 | M | D | 9,988 | $0.00 | 0 | D | $48.34 · 2020-07-10 to 2027-07-09 | 9,988 Common Shares | (F2) Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |